Immunome Financial Overview
Immunome's market cap is currently $1.75B. The company's EPS TTM is $-0.65; its P/E ratio is ―; Immunome is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
